Medidata Solutions Announces Definitive Agreement to Acquire Clinical Force
Medidata Solutions announced that it has entered into a definitive agreement to acquire Clinical Force for undisclosed proceeds.The acquisition is subject to various standard closing conditions and is expected to be completed early in Medidata’s fiscal third quarter ending September 30, 2011.
Research sponsors and contract research organizations (CROs) are increasingly looking to reduce the financial and operational management burden of clinical trials, streamline clinical processes and increase visibility to timely information that enhances governance and decision-making. While software systems aiming to address these business challenges have typically required complex implementation projects with large upfront investments, lengthy timelines and ongoing maintenance costs, Clinical Force’s alternative CTMS solution eliminates these risks, providing a proven technology to customers over the past seven years.
Based in the UK, with customers in North America, Europe and India including more than a dozen CROs, Clinical Force has successfully enabled its customers to readily adopt CTMS with a low-risk solution that is quick-to-deploy, easy-to-use, flexible and modular. Research organizations large and small can selectively and rapidly automate a wide range of processes, including time and expense management, milestone tracking, monitoring reports and clinical investigator payments. Current Clinical Force revenue is not material to Medidata in 2011, but it is expected to grow based on access to Medidata’s global capabilities.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
